Built for Supply Chain Resiliency and Reliability.

Phlow’s U.S.-based manufacturing infrastructure is strategically designed to support R&D and manufacturing scale-up for small and large commercial volumes. This effort aims to address the structural vulnerabilities in international supply chains and safeguard America’s economic and national security.

Phlow’s Research & Development Laboratory.

Phlow’s state-of-the-art R&D lab, co-located with the U.S. Pharmacopoeia, is located at the Advanced Pharmaceutical Development Center at Virginia Biotechnology Research Park in Richmond, Virginia.

The APDC offers R&D services for small molecule Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) that leverage advanced manufacturing technologies using the latest process and analytical equipment. Here we focus on initial route scouting and process development, coupled with USP’s industry leading analytical capabilities.

Located in Richmond, VA

Kilo-Scale cGMP Facility.

Phlow’s Kilo Facility is an advanced manufacturing facility capable of both batch and continuous processes for producing up to 500 kg of API annually. This facility also contains highly-automated equipment and up to 100 L reactors across two cGMP suites, each with two separate walk-in hoods and 24 associated fixed, solvent, reagent and collection tanks. Phlow’s Kilo facility also houses a non-cGMP suite and R&D lab space with 12 fume hoods and supporting analytical equipment, plus an automation lab to ensure Phlow remains on the cutting edge of advanced manufacturing equipment and processes.

Located in Petersburg, VA

Kilo-Scale cGMP Facility.

Phlow’s Kilo Facility is an advanced manufacturing facility capable of both batch and continuous processes for producing up to 500 kg of API annually. This facility also contains highly-automated equipment and up to 100 L reactors across two cGMP suites, each with two separate walk-in hoods and 24 associated fixed, solvent, reagent and collection tanks. Phlow’s Kilo facility also houses a non-cGMP suite and R&D lab space with 12 fume hoods and supporting analytical equipment, plus an automation lab to ensure Phlow remains on the cutting edge of advanced manufacturing equipment and processes.

Metric-Ton Scale cGMP Facility.

Phlow’s Metric-Ton scale facility can produce 100 metric tons of API annually, through continuous and batch mode production. This large-scale, advanced manufacturing facility is equipped with multiple production lines and dedicated drying suites.

Located in Petersburg, VA

Undisclosed location in U.S.

Strategic Active Pharmaceutical Ingredient Reserve.

The Strategic API Reserve (SAPIR™) is built to store and supply our Nation’s critical active ingredients that can be rapidly converted to finished essential medicine and medical countermeasure products in the event of a national disaster, global war, trade dispute with a foreign adversary, or future public health emergency. As part of our unwavering commitment and partnership with the U.S. government, Phlow stands vigilant with the SAPIR to respond to global disruptions, manage shortages, and stabilize the supply chain in times of crisis.

Undisclosed location in U.S.